Afinitor is a brand-name drug that’s prescribed for certain seizures, cancers, and tumors. Afinitor contains the active ingredient everolimus and may not be safe to take during pregnancy and ...

Afinitor (everolimus) is a prescription drug that’s used to treat some types of cancer, seizures, and certain tumors. This drug can interact with other medications and some supplements. For ...

NHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus) for TSC-related refractory epilepsy from April 2019. The new decision means that Afinitor will be ...

While Welireg (belzutifan) has outperformed Afinitor (everolimus) in OS at 12 months and 24 months, the results have not achieved statistical significance. The OS gap between Welireg and Afinitor ...

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

The US FDA has approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast ...

Synthetic derivatives of rapamycin have now been approved or are being investigated as therapeutics in cancer (Torisel, temsirolimus; Afinitor, everolimus; ridaforolimus) and in other diseases.

However, bucking that trend is Novartis, which had three approvals — Afinitor [everolimus, for the treatment of renal cell carcinoma], Coartem [artemether and lumefantrine, for the treatment of ...